Education
About Us
Working with TipRanks
Follow Us
Puma Biotechnology (PBYI)
NASDAQ:PBYI
Earnings Data
Report Date
Feb 26, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.19Last Year’s EPS
0.39Same Quarter Last Year
Moderate Sell
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call reflects a balanced sentiment. While positive trends such as increased U.S. net sales of NERLYNX and positive net income indicate financial stability, challenges remain with declining royalty revenues and new prescriptions. Clinical trials are progressing well, but international sales and new patient starts pose significant hurdles.Company Guidance
Increase in NERLYNX U.S. Net Sales
U.S. net sales of NERLYNX in Q3 2025 were $51.8 million, up from $48.8 million in Q3 2024, showing positive sales momentum in the U.S. market.
Positive Net Income Achievement
Puma reported a net income of $8.8 million in Q3 2025, compared to $5.9 million in Q2 2025, marking a stable financial performance.
Successful Enrollment in Clinical Trials
Ahead-of-schedule enrollment in the ALISCA-Breast1 trial with 98 patients enrolled and 14 in screening, indicating strong progress in clinical research.
Demand Growth in SD Channel
The SD channel showed a strong demand growth of 11% quarter-over-quarter and 25% year-over-year, indicating strategic success in distribution.
PBYI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
PBYI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 06, 2025 | $4.90 | $5.99 | +22.24% |
Aug 07, 2025 | $3.29 | $3.69 | +12.16% |
May 08, 2025 | $3.07 | $2.91 | -5.21% |
Feb 27, 2025 | $2.99 | $3.58 | +19.73% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Puma Biotechnology (PBYI) report earnings?
Puma Biotechnology (PBYI) is schdueled to report earning on Feb 26, 2026, After Close (Confirmed).
What is Puma Biotechnology (PBYI) earnings time?
Puma Biotechnology (PBYI) earnings time is at Feb 26, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PBYI EPS forecast?
PBYI EPS forecast for the fiscal quarter 2025 (Q4) is 0.19.